Adial Pharmaceuticals
ADIL
17 hedge funds and large institutions have $335K invested in Adial Pharmaceuticals in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
425% more capital invested
Capital invested by funds: $63.8K → $335K (+$271K)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
13% more funds holding
Funds holding: 15 → 17 (+2)
3.87% more ownership
Funds ownership: 2.5% → 6.37% (+3.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$63.6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$58.5K |
| 3 |
SG
StoneX Group
New York
|
+$39K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$36.9K |
| 5 |
CUAMC
China Universal Asset Management Company
Shanghai,
China
|
+$15.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$23.5K |
| 2 |
BlackRock
New York
|
-$1.6K |
| 3 |
CIAM
Caitong International Asset Management
Hong Kong
|
-$27 |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$7 |
ADIL Hedge Fund Activity: Q2 2026 in Review
17 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals (ADIL) for Q2 2026, worth a combined $335K — up 425% from $63.8K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ADIL positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $63.6K. The largest seller was Geode Capital Management, cutting an estimated $23.5K.
- 17 institutional investors held Adial Pharmaceuticals (ADIL) as of Q2 2026, up from 15 in Q1 2026.
- Funds reported $335K of Adial Pharmaceuticals stock for Q2 2026, up 425% quarter-over-quarter.
- 4 funds opened new Adial Pharmaceuticals positions in Q2 2026 and 2 closed out, a net change of +2 holders.
- The largest Adial Pharmaceuticals buyer in Q2 2026 was Jane Street, an estimated $63.6K added.
- The largest Adial Pharmaceuticals seller in Q2 2026 was Geode Capital Management, an estimated $23.5K sold.
Based on aggregated 13F filings for Q2 2026.